The Food and Drug Administration Office of Women's Health: Impact of Science on Regulatory Policy: An Update

被引：7

作者：

Elahi, Merina ^{[1
]}

Eshera, Noha ^{[1
]}

Bambata, Nkosazana ^{[1
]}

Barr, Helen ^{[2
]}

Lyn-Cook, Beverly ^{[3
]}

Beitz, Julie ^{[4
]}

Rios, Maria ^{[5
]}

Taylor, Deborah R. ^{[5
]}

Lightfoote, Marilyn ^{[2
]}

Hanafi, Nada ^{[2
]}

DeJager, Lowri ^{[6
]}

Wiesenfeld, Paddy ^{[6
]}

Scott, Pamela E. ^{[1
]}

Fadiran, Emmanuel O. ^{[1
]}

Henderson, Marsha B. ^{[1
]}

机构：

[1] US FDA, Off Womens Hlth, WO Bldg 32,Room 2312,10903 New Hampshire Ave, Silver Spring, MD 20993 USA

[2] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD 20993 USA

[3] US FDA, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA

[4] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA

[5] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA

[6] US FDA, Ctr Food Safety & Appl Nutr, Silver Spring, MD 20993 USA

来源：

JOURNAL OF WOMENS HEALTH | 2016年 / 25卷 / 03期

关键词：

CARDIAC RESYNCHRONIZATION THERAPY; MOLECULAR ENTITY DRUGS; PHASE CLINICAL-TRIALS; RAT UTERINE GROWTH; PREDICT DISPOSITION; SEX-DIFFERENCES; BREAST-CANCER; PREGNANT-WOMEN; TUMOR SIZE; PBPK MODEL;

D O I：

10.1089/jwh.2015.5671

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

The U.S. Food and Drug Administration Office of Women's Health (FDA OWH) has supported women's health research for similar to 20 years, funding more than 300 studies on women's health issues, including research on diseases/conditions that disproportionately affect women in addition to the evaluation of sex differences in the performance of and response to medical products. These important women's health issues are studied from a regulatory perspective, with a focus on improving and optimizing medical product development and the evaluation of product safety and efficacy in women. These findings have influenced industry direction, labeling, product discontinuation, safety notices, and clinical practice. In addition, OWH-funded research has addressed gaps in the knowledge about diseases and medical conditions that impact women across the life span such as cardiovascular disease, pregnancy, menopause, osteoporosis, and the safe use of numerous medical products.

引用

页码：222 / 234

页数：13

共 50 条

[21] Working to Advance Health Equity: The US Food and Drug Administration Office of Minority Health and Health Equity
Araojo, Richardae
JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2021, 113 (03) : 359 - 362
[22] Regulatory science: a special update from the United States Food and Drug Administration - Preclinical issues and status of investigation of botanical drug products in the United States
Wu, KM
DeGeorge, JG
Atrakchi, A
Barry, E
Bigger, A
Chen, C
Du, T
Freed, L
Geyer, H
Goheer, A
Jacobs, A
Jean, D
Rhee, H
Osterberg, R
Schmidt, W
Farrelly, JG
TOXICOLOGY LETTERS, 2000, 111 (03) : 199 - 202
[23] Food and Drug Administration Beyond the 2001 Government Accountability Office Report: Promoting Drug Safety for Women
Jenkins, Marjorie R.
Munoz, Monica A.
Bak, Daniel
Chai, Grace
Ready, Travis
South, Erin M.
Zinn, Rebekah L.
Zusterzeel, Robbert
Woodcock, Janet
JOURNAL OF WOMENS HEALTH, 2021, 30 (07) : 927 - 934
[24] Addressing health disparities in the Food and Drug Administration's artificial intelligence and machine learning regulatory framework
Ferryman, Kadija
JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION, 2020, 27 (12) : 2016 - 2019
[25] Food and Drug Administration Regulation of Tobacco: Integrating Science, Law, Policy, and Advocacy
Villanti, Andrea C.
Vargyas, Ellen J.
Niaura, Raymond S.
Beck, Stacy E.
Pearson, Jennifer L.
Abrams, David B.
AMERICAN JOURNAL OF PUBLIC HEALTH, 2011, 101 (07) : 1160 - 1162
[26] Cardiac resynchronization devices - The food and drug administration's regulatory considerations
Moynahan, M
Faris, OP
Lewis, BM
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 46 (12) : 2325 - 2328
[27] The state of science at the Food and Drug Administration
Hutt, Peter Barton
ADMINISTRATIVE LAW REVIEW, 2008, 60 (02) : 431 - 486
[28] SCIENCE, DRUGS, AND FOOD AND DRUG ADMINISTRATION
DEHAEN, P
NEW YORK STATE JOURNAL OF MEDICINE, 1971, 71 (13) : 1644 - &
[29] Women's health and the environment: Innovations in science and policy
Haynes, SG
Lynch, BS
Biegel, R
Malliou, E
Rudick, J
Sassaman, AP
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2000, 9 (03): : 245 - 273
[30] Advanced science education in the regulatory arena: The Center for Drug Evaluation and research experience at the Food and Drug Administration
Ajayi, FO
Wilcox, DF
Uhl, K
Quinn, J
JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (07): : 711 - 717

← 1 2 3 4 5 →